Evidence map›Paper›PMID 34845183›Full record

ArticleBlood cancer journal2021

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism.

Marko Lucijanic, Ivan Krecak, Ena Soric, Martina Sedinic, Anica Sabljic, Lovorka Derek, Ozren Jaksic, Rajko Kusec

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Mucosal implications of oral Jak3-targeted drugs in COVID patients.Molecular medicine (Cambridge, Mass.) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marko LucijanicHematology Department, University Hospital Dubrava, Zagreb, Croatia. markolucijanic@yahoo.com.ORCID 0000-0002-1372-2040
Ivan KrecakInternal Medicine Department, General hospital Sibenik, Sibenik, Croatia.
Ena SoricHematology Department, University Hospital Dubrava, Zagreb, Croatia.
Martina SedinicHematology Department, University Hospital Dubrava, Zagreb, Croatia.
Anica SabljicHematology Department, University Hospital Dubrava, Zagreb, Croatia.
Lovorka DerekClinical Department for Laboratory Diagnostics, University Hospital Dubrava, Zagreb, Croatia.
Ozren JaksicHematology Department, University Hospital Dubrava, Zagreb, Croatia.
Rajko KusecHematology Department, University Hospital Dubrava, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overBlood PlateletsCOVID-19FemaleHumansMaleMiddle AgedMyeloproliferative DisordersPrognosisSARS-CoV-2ThrombocytosisVenous Thromboembolism

Identifiers

PMID34845183
PMCPMC8629336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.